It focuses on a study done to examine the effect of a single yearly infusion of intravenous zoledronic acid (ZA) on the risk for vertebral and hip fractures in patients with osteoporosis. It describes the study involving 3889 patients, the results of which showed that an yearly dose of ZA ...
The purpose of this study was to estimate the cost-effectiveness of once-yearly injection of zoledronic acid for the treatment of osteoporosis in Japan. Methods A patient-level state-transition model was developed to predict the outcome of patients with osteoporosis who have experienced a previous ...
Infusion of Zoledronic Acid 5mg Versus a Once-Weekly 70-mg Oral Alendronate in the Treatment of Male?Osteoporosis: A Randomized, Multicenter, Double-Blind, Active-Controlled Study Clarke,L B. - 《Yearbook of Medicine》 被引量: 0发表: 2011年 Efficacy and safety of a once-yearly i.v. In...
The Osteoporosis Jab; Twice-Yearly Treatment Cuts the Risk of Spinal Fracture in Women by Two ThirdsByline: Jenny Hope Medical CorrespondentDaily Mail (London)
Postmenopausic osteoporosis treatment with yearly doses of intravenous Zoledronic acid. A Venezuelan Observational StudySNPs PSMD9LinkageHypercholesterolemiaBackground: Although chicken oviduct is a useful model and target tissue for reproductive biology and transgenesis, little is known because of the ...
Once-Yearly zoledronic acid 5 mg infusion for treatment of postmenopausal osteoporosis: Effects on fracture incidence in patient subgroups from the HORIZON-PFT studyR., EastellD.M., BlackS., BoonenA.R., McLellanS.R., CummingsP.D., Delmas...
Elizabeth HristovRichard OsborneAndrew DaltonElsevier Inc.BoneWark, J., Hristov, E., Osborne, R., & Dalton, A. (2010). Treatment-naive osteoporosis patients strongly prefer once-yearly intravenous therapy: A time trade-off study. Bone, 46 , S33....
A., DorstP., FarahmandRinge JD, Dorst A, Farahmand P. Comparing once yearly zoledronic acid with once weekly generic alendronate in the treatment of established male osteoporosis [abstract no. P840]. Osteoporos Int. 2010;21(Suppl 1):S357....
BACKGROUND: A single infusion of intravenous zoledronic acid decreases bone turnover and improves bone density at 12 months in postmenopausal women with osteoporosis. We assessed the effects of annual infusions of zoledronic acid on fracture risk during a 3-year period. METHODS: In this double-...
Osteoporosis InternationalMoriwaki K, Mouri M, Hagino H (2017) Cost-effectiveness anal- ysis of once-yearly injection of zoledronic acid for the treatment of osteoporosis in Japan. Osteoporos Int 28(6):1939-1950Moriwaki K, Mouri M, Hagino H. Cost-effectiveness analysis of once-yearly injection ...